Research at Merrimack’s Center for Biotechnology and Biomedical Sciences
Honors Student Alisha Wilkinson ’12 interned at Nexcelom Bioscience in Lawrence during her senior year, has co-authored four manuscripts published in peer-reviewed journals and is working at Massachusetts General Hospital.
“Since being published is no easy feat, having a publication on your resume makes you stand out to future employers,” Wilkinson said.
In his internship, Daniel Laverty ’13 worked on developing cell-based assays that utilize an image cytometry device produced by Nexcelom. He’s submitted manuscripts to the Journal of Industrial Microbiology and the Journal of Immunological Methods and is working with Dr. Jimmy Franco on synthesizing potential drugs to treat tuberculosis.
“It was really great to have the internship at Nexcelom because it gave me experience doing independent research in an industry setting,” Laverty said.
Since 2009, the CBBS has provided students an academic foundation to meet rapidly evolving opportunities and challenges biological scientists face in the 21st century. The CBBS develops new programs, fosters interdisciplinary collaboration and establishes community and corporate partnerships.
“Our students benefit by participating in research projects sponsored by the CBBS. Our corporate partners provide mentoring, internships and actual employment,” said Dr. Janine M. LeBlanc-Straceski, a biology professor and CBBS director.
Nexcelom researchers have had several papers published with Merrimack students and faculty as co-authors and make presentations on campus. They also use the CBBS, and students visit the company’s facility. Bach Pharma has used the CBBS for product preparation, and Pfizer has donated laboratory equipment.
Merrimack students conducting summer research in the Center for Biotechnology and Biomedical Sciences. The students are working on an interdisciplinary project to discover novel chemotherapeutics for the treatment of Histoplasmosis.
On March 6th, 2014 the Department of Biology and the Center for Biotechnology and Biomedical Sciences held Pfizer Pharma Day.